Sharon K. Rudolph
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Cancer Treatment and Pharmacology, Cancer Mechanisms and Therapy, Quinazolinone synthesis and applications, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity(2007)512 cited
- → Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor(2008)342 cited
- → Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb®, GW572016) in an expanded panel of human normal and tumour cell lines(2007)174 cited
- → Generation and characterization of quinolone-specific DNA aptamers suitable for water monitoring(2015)121 cited
- → High-Affinity Inhibitors of Dihydrofolate Reductase: Antimicrobial and Anticancer Activities of 7,8-Dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with Small Molecular Size(1996)106 cited
- → Selective Inhibitors of Candida albicans Dihydrofolate Reductase: Activity and Selectivity of 5-(Arylthio)-2,4-diaminoquinazolines(1995)69 cited
- → Immunogenicity of Thrombopoietin Mimetic Peptide GW395058 in BALB/c Mice and New Zealand White Rabbits: Evaluation of the Potential for Thrombopoietin Neutralizing Antibody Production in Man(1999)47 cited
- → Synthesis of 1,3‐diamino‐7,8,9,10‐tetrahydropyrido[3,2‐f]‐quinazolines. Inhibitors of Candida albicans dihydrofolate reductase as potential antifungal agents(1997)44 cited
- → Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase(2005)30 cited
- → Alkynyl pyrimidines as dual EGFR/ErbB2 kinase inhibitors(2006)25 cited